#AUA14 - Poster: Reduction in urinary incontinence and improvement in quality of life with onabotulinumtoxinA in overactive bladder patients is unaffected by the use of clean intermittent catheterization or the presence of urinary tract infection

ORLANDO, FL USA (UroToday.com) - Presented by David Sussman,¹ Jennifer Gruenenfelder,² Heinrich Schulte-Baukloh,³ Steven Guard,⁴ Yan Zheng,⁵ and Karel Everaert⁶ at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

¹Rowan University School of Osteopathic Medicine, Stratford, NJ, USA; ²Orange County Urology Associates, Laguna Hills, CA, USA; ³St. Hedwig-Krankenhaus, Berlin, Germany; ⁴Allergan, Ltd., Marlow, UK; ⁵Allergan, Inc., Bridgewater, NJ, USA; ⁶Ghent University Hospital, Gent, Belgium